METASTRA

Computer-Aided Effective Fracture Risk Stratification of Patients with Vertebral Metastases for Personalised Treatment through Robust Computational Models Validated in Clinical Settings

Programme
Horizon Europe & sub-programmes
Duration
60 months (July 2023 – June 2028)
Project funding
≈ €7 million
Project partners
15

What the project is about

METASTRA aims to transform the way clinicians assess fracture risk in cancer patients with vertebral metastases. METASTRA will develop innovative artificial intelligence and Physiology-based (VPH) mechanical computational models to accurately stratify patients with spine metastasis who are at high risk of fractures and identify personalised surgical treatments. The project will integrate the computational models into a user-friendly Decision Support System (DSS) tailored to meet regulatory requirements and future commercialisation opportunities. METASTRA’s innovative guidelines for patient stratification and management are expected to significantly reduce uncertain diagnoses from the current 60% to a mere 20% of cases, potentially saving up to 2.4 billion euros annually in healthcare expenditures.

Coordinator

Professor Luca Cristofolini

Alma Mater Studiorum – Università di Bologna

Email

Your EURICE
contact

Your contact
Dr Sanja Šale
Senior Innovation Manager
Email

Explore THE COURT

Discover THE COURT, the EURICE environment where projects, expertise and partners connect across six innovation ecosystems.

Enter THE COURT